Effectiveness of Tocilizumab in COVID-19 Patients with Pneumonia: A Systematic Review.

Background And Objective: COVID-19 contributes significantly to global morbidity and mortality. Age-related comorbidities elevate the risk of severe cases. Studies have recently demonstrated that widely available medications, including tocilizumab (TCZ), can manage severe symptoms.